Skip to main content
. 2021 Aug 9;8:701430. doi: 10.3389/fnut.2021.701430

Table 2.

Associations of total and specific dietary fat intake with all-cause mortality.

Variables (g/day) Median Cohort (n) Cases (n) Model 1a Model 2b Model 3c Model 4d
Total fat
Q1 (<35.30) 27.61 20,382 5,007 Reference group Reference group Reference group
Q2 (≥35.30 to <48.48) 41.95 20,366 4,594 0.94 (0.90–0.98),
p = 0.002
0.92 (0.89–0.96),
p < 0.001
0.93 (0.89–0.97),
p = 0.001
Q3 (≥48.48 to <63.09) 55.33 20,362 4,652 0.94 (0.90–0.98),
p = 0.002
0.90 (0.86–0.94),
p < 0.001
0.91 (0.87–0.95),
p < 0.001
Q4 (≥63.09 to <85.23) 72.38 20,362 4,772 0.95 (0.92–0.99),
p = 0.024
0.88 (0.83–0.91),
p < 0.001
0.89 (0.84–0.93),
p < 0.001
Q5 (≥85.23) 106.11 20,365 5,116 1.05 (1.01–1.10),
p = 0.013
0.85 (0.79–0.90),
p < 0.001
0.88 (0.83–0.94),
p < 0.001
pfor trend <0.001 pfor trend <0.001 pfor trend <0.001
SFAs
Q1 (<10.62) 8.23 20,390 4,861 Reference group Reference group Reference group Reference group
Q2 (≥10.62 to <14.93) 12.76 20,373 4,554 0.96 (0.92–1.00),
p = 0.054
0.94 (0.90–0.98),
p = 0.004
0.95 (0.91–0.99),
p = 0.022
0.97 (0.93–1.02),
p = 0.215
Q3 (≥ 14.93 to <19.86) 17.21 20,369 4,621 0.98 (0.94–1.02),
p = 0.235
0.94 (0.90–0.98),
p = 0.005
0.96 (0.92–1.01),
p = 0.089
1.00 (0.96–1.05),
p = 0.886
Q4 (≥ 19.86 to <27.53) 23.07 20,339 4,823 1.02 (0.98–1.06),
p = 0.34
0.94 (0.90–0.99),
p = 0.017
0.97 (0.92–1.02),
p = 0.192
1.03 (0.98–1.09),
p = 0.287
Q5 (≥ 27.53) 34.96 20,366 5,282 1.14 (1.09–1.19),
p < 0.001
0.97 (0.91–1.03),
p = 0.320
1.02 (0.96–1.08),
p = 0.586
1.13 (1.05–1.22),
p = 0.001
pfor trend <0.001 pfor trend = 0.805 pfor trend = 0.215 pfor trend <0.001
TFAs
Q1 (<2.08) 1.57 20,523 4,870 Reference group Reference group Reference group Reference group
Q2 (≥ 2.08 to <2.98) 2.53 20,366 4,482 0.95 (0.91–0.99),
p = 0.007
0.92 (0.88–0.96),
p < 0.001
0.92 (0.88–0.96),
p < 0.001
0.93 (0.89–0.97),
p = 0.001
Q3 (≥ 2.98 to <4.00) 3.45 20,291 4,637 0.98 (0.94–1.02),
p = 0.239
0.93 (0.89–0.97),
p = 0.001
0.93 (0.89–0.97),
p = 0.002
0.95 (0.91–0.99), p = 0.028
Q4 (≥ 4.00 to <5.58) 4.67 20,343 4,967 1.03 (0.99–1.07),
p = 0.147
0.95 (0.90–0.99),
p = 0.019
0.95 (0.91–1.00),
p = 0.052
0.98 (0.93–1.03),
p = 0.475
Q5 (≥ 5.58) 7.09 20,314 5,185 1.09 (1.05–1.13),
p < 0.001
0.91 (0.86–0.96),
p = 0.001
0.92 (0.87–0.98),
p = 0.005
0.97 (0.91–1.04),
p = 0.372
pfor trend <0.001 pfor trend = 0.036 pfor trend = 0.091 pfor trend = 0.899
PUFAs
Q1 (<7.95) 6.21 20,387 5,298 Reference group Reference group Reference group Reference group
Q2 (≥ 7.95 to <10.93) 9.47 20,409 4,748 0.90 (0.87–0.94),
p < 0.001
0.89 (0.86–0.93),
p < 0.001
0.90 (0.86–0.93), p < 0.001 0.90 (0.87–0.94),
p < 0.001
Q3 (≥ 10.93 to <14.26) 12.49 20,315 4,641 0.87 (0.84–0.91), p < 0.001 0.83 (0.80–0.87),
p < 0.001
0.84 (0.80–0.87),
p < 0.001
0.85 (0.81–0.89),
p < 0.001
Q4 (≥ 14.26 to <19.21) 16.37 20,389 4,644 0.88 (0.84–0.91), p < 0.001 0.78 (0.75–0.82),
p < 0.001
0.80 (0.76–0.83),
p < 0.001
0.82 (0.77–0.86),
p < 0.001
Q5 (≥ 19.21) 23.89 20,337 4,810 0.92 (0.88–0.96),
p < 0.001
0.73 (0.69–0.77),
p < 0.001
0.75 (0.70–0.79),
p < 0.001
0.79 (0.73–0.85),
p < 0.001
pfor trend = 0.001. pfor trend <0.001. pfor trend <0.001. pfor trend <0.001.
MUFAs
Q1 (<12.95) 9.96 20,406 5,022 Reference group Reference group Reference group Reference group
Q2 (≥ 12.95 to <18.07) 15.52 20,343 4,564 0.93 (0.89–0.97),
p < 0.001
0.91 (0.87–0.95),
p < 0.001
0.92 (0.88–0.96),
p < 0.001
0.93 (0.89–0.97),
p = 0.001
Q3 (≥ 18.07 to <23.80) 20.77 20,379 4,605 0.92 (0.89–0.96),
p < 0.001
0.88 (0.84–0.92),
p < 0.001
0.89 (0.85–0.93),
p < 0.001
0.91 (0.87–0.96),
p < 0.001
Q4 (≥ 23.80 to <32.49) 27.46 20,344 4,843 0.95 (0.92–0.99),
p = 0.019
0.86 (0.82–0.91),
p < 0.001
0.88 (0.84–0.92),
p < 0.001
0.91 (0.86–0.96),
p = 0.001
Q5 (≥ 32.49) 40.66 20,365 5,107 1.04 (1.00–1.08),
p = 0.081
0.83 (0.77–0.88),
p < 0.001
0.85 (0.80–0.91),
p < 0.001
0.91 (0.84–0.99), p = 0.021
pfor trend = 0.001 pfor trend <0.001 pfor trend <0.001 pfor trend = 0.044
P-MUFAs
Q1 (<4.88) 3.65 20,414 5260 Reference group Reference group Reference group Reference group
Q2 (≥ 4.88 to <7.18) 6.01 20,340 4840 0.92 (0.88–0.95),
p < 0.001
0.92 (0.89–0.96),
p < 0.001
0.93 (0.89–0.97),
p < 0.001
0.94 (0.90–0.98),
p = 0.003
Q3 (≥ 7.18 to <9.89 ) 8.44 20,393 4611 0.87 (0.83–0.90),
p < 0.001
0.85 (0.81–0.89),
p < 0.001
0.85 (0.82–0.89),
p < 0.001
0.87 (0.83–0.91),
p < 0.001
Q4 (≥ 9.89 to <14.16 ) 11.67 20,355 4654 0.85 (0.82–0.89),
p < 0.001
0.80 (0.77–0.84),
p < 0.001
0.81 (0.77–0.85), p < 0.001 0.84 (0.80–0.89),
p < 0.001
Q5 (≥ 14.16) 18.44 20,335 4776 0.87 (0.84–0.91),
p < 0.001
0.76 (0.72–0.80),
p < 0.001
0.77 (0.73–0.81),
p < 0.001
0.83 (0.77–0.89),
p < 0.001
pfor trend <0.001 pfor trend <0.001 pfor trend <0.001 pfor trend <0.001
A-MUFAs
Q1 (<6.63 ) 4.95 20,388 4702 Reference group Reference group Reference group Reference group
Q2 (≥ 6.63 to <9.64) 8.11 20,393 4620 1.02 (0.98–1.06),
p = 0.332
0.99 (0.95–1.04),
p = 0.773
1.00 (0.96–1.05),
p = 0.862
1.00 (0.96–1.04),
p = 0.998
Q3 (≥ 9.64 to <13.08 ) 11.23 20,338 4484 0.98 (0.94–1.02),
p = 0.425
0.94 (0.90–0.99),
p = 0.013
0.96 (0.92–1.01),
p = 0.110
0.96 (0.91–1.00),
p = 0.061
Q4 (≥ 13.08 to <18.48) 15.33 20,358 5002 1.09 (1.05–1.14),
p < 0.001
1.01 (0.97–1.07),
p = 0.472
1.04 (0.99–1.09),
p = 0.086
1.02 (0.97–1.08),
p = 0.39
Q5 (≥18.48 ) 23.76 20,360 5333 1.20 (1.15–1.25),
p < 0.001
1.04 (0.98–1.10),
p = 0.213
1.08 (1.02–1.15),
p = 0.009
1.03 (0.96–1.11),
p = 0.402
pfor trend <0.001 pfor trend = 0.065 pfor trend = 0.001 pfor trend = 0.250

SFAs, saturated fatty acids; PUFAs, polyunsaturated fatty acids; MUFAs, monounsaturated fatty acids; TFAs, trans-fatty acids; P-MUFAs, MUFAs from plant; A-MUFAs, MUFAs from animal; Q, quintile.

a

Adjusted for age (continuous) and gender (male vs. female).

b

Additionally adjusted for race (non-Hispanic White vs. Other), body mass index (continuous), education (≤ high school vs. ≥ some college), smoking status (never vs. former ≤ 15 years since quit vs. former > 15 years since quit vs. former year since quit unknown vs. current smoker ≤ 1 pack per day vs. current smoker > 1 pack per day vs. current smoker intensity unknown), total energy intake (continuous), alcohol drinking status (never vs. former vs. current), study center (categorical), marital status (married vs. not married), randomization arm (screening group vs. control group), aspirin use (yes vs. no), history of hypertension (yes vs. no), history of diabetes (yes vs. no), vegetables intake (continuous), and fruit intake (continuous).

c

Further adjusted for history of stroke (yes vs. no) and history of heart attack (yes vs. no).

d

Additionally adjusted for other remaining fatty acids.